Parking Idle Cash At 5% To 6% Yields
The average BDC baby bond currently has an average effective yield of 6.0% and yield-to-maturity of 5.5% perfectly suitable for…
Stock Analysis
Ending Anonymity: Why The WEF’s Partnership Against Cybercrime Threatens The Future Of Privacy
With many focusing on tomorrow’s Cyber Polygon exercise, less attention has been paid to the World Economic Forum’s real ambitions…
How a Full-Blown Cyberwarfare Can Change the World
This blog is about the How a Full-Blown Cyberwarfare Can Change the World. We will try our best so that you understand this guide…
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Rekor Systems, Inc. f/k/a Novume Solutions, Inc., of Class Action Lawsuit and Upcoming Deadline – REKR; NVMM
Pomerantz LLP announces that a class action lawsuit has been filed against Rekor Systems, Inc. f/k/a Novume Solutions, Inc. (“Rekor”…
Goodness Growth: Forgotten New York License Holder
Goodness Growth was lost in the shuffle following a name change and new growth initiatives. Read more about this cannabis stock…
Lower Is Better With Koninklijke KPN Share Prices
KPN’s stock doesn’t have much upside and can have some downside. Picking up the stock as cheap as possible is recommended for…
Understanding Alibaba, Why It’s Better Than Amazon?
Alibaba is entirely misunderstood by most investors. It is more an ecosystem than a company as I shall explain. Learn why BABA…
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Rocket Companies, Inc. of Class Action Lawsuit and Upcoming Deadline – RKT
NEW YORK, July 18, 2021 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Companies,…
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Rocket Companies, Inc. of Class Action Lawsuit and Upcoming Deadline – RKT
Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Companies, Inc. (“Rocket” or the “Company”)…
2 Top Pharma Stocks to Buy Right Now
The market may be underappreciating the long-term prospects of Johnson & Johnson and Merck.